CRMD
CorMedix Inc.
Biotechnology · Healthcare · United States
8.14
close · 2026-08-13
value
86
cheaper than peers86
quality
96
stronger fundamentals96
ranked against
Biotechnology (commercial)
value
quality
101 peerswide variation
Value inputs
| measure | company | vs peers |
| price to sales | 1.47× | 97 |
| EV to EBITDA | 2.46× | 87 |
| price to book | 1.46× | 86 |
| forward P/E | 23.26× | 42 |
4 of 12 measures available
Quality inputs
| measure | company | vs peers |
| operating margin | 50.0% | 97 |
| return on equity | 65.6% | 94 |
| revenue growth | 226.1% | 84 |
| debt to equity | 33.7% | 39 |
4 of 4 measures available
Facts
| market cap | $639M |
| free cash flow | $119.8M |
| employees | 191 |
| first trade | 2010-05-13 |
| next earnings | 2026-08-13 |
| fundamentals updated | 2026-08-04 |